• Amsterdam UMC, Vrije Universiteit Amsterdam, Hematology Laboratory, Cancer Center Amsterdam, De Boelelaan 1117 Amsterdam The Netherlands

1993 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
2019

Can we incorporate MRD assessment into clinical practice in AML?

Ossenkoppele, G., Schuurhuis, G. J., van de Loosdrecht, A. & Cloos, J., 1 Jun 2019, In : Best Practice and Research: Clinical Haematology. 32, 2, p. 186-191 6 p.

Research output: Contribution to journalReview articleAcademicpeer-review

2018

How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance?

Jaramillo Mantilla, CA., Al Saig, F., Cloos, J., Jansen, G. & Peters, GJ., 19 Mar 2018, In : Cancer Drug Resistance. 1, p. 6-29 24 p., DOI: 10.20517/cdr.2018.02.

Research output: Contribution to journalReview articleAcademicpeer-review

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

Schuurhuis, G. J., Heuser, M., Freeman, S., Béné, M-C., Buccisano, F., Cloos, J., Grimwade, D., Haferlach, T., Hills, R. K., Hourigan, C. S., Jorgensen, J. L., Kern, W., Lacombe, F., Maurillo, L., Preudhomme, C., van der Reijden, B. A., Thiede, C., Venditti, A., Vyas, P., Wood, B. L. & 4 others, Walter, R. B., Döhner, K., Roboz, G. J. & Ossenkoppele, G. J., 22 Mar 2018, In : Blood. 131, 12, p. 1275-1291 17 p.

Research output: Contribution to journalReview articleAcademicpeer-review

2017

Leukemic stem cells: identification and clinical application

Hanekamp, D., Cloos, J. & Schuurhuis, G. J., May 2017, In : American Journal of Hematology. 105, 5, p. 549-557 9 p.

Research output: Contribution to journalReview articleAcademicpeer-review

2009

Role of tyrosine phosphatase inhibitors in cancer treatment with emphasis on SH2 domain-containing tyrosine phosphatases (SHPs)

Irandoust, M., van den Berg, T. K., Kaspers, G. J. L. & Cloos, J., Feb 2009, In : Anti-Cancer Agents in Medicinal Chemistry. 9, 2, p. 212-20 9 p.

Research output: Contribution to journalReview articleAcademicpeer-review

2006

Proteasome inhibition as novel treatment strategy in leukaemia

Vink, J., Cloos, J. & Kaspers, G. J. L., 1 Aug 2006, In : British Journal of Haematology. 134, 3, p. 253-262 10 p.

Research output: Contribution to journalReview articleAcademicpeer-review

1996

Mutagen sensitivity: Enhanced risk assessment of squamous cell carcinoma

Cloos, J., Reid, C. B. A., Snow, G. B. & Braakhuis, B. J. M., 1 Nov 1996, In : European Journal of Cancer Part B: Oral Oncology. 32, 6, p. 367-372 6 p.

Research output: Contribution to journalReview articleAcademicpeer-review